{"transactions":[{"id":1165834,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80509,"kind":"person","name":"Becher Charles","position":1,"cik":"0001775310","reported_name":"Becher Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-04-25T12:35:39.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":31326,"price":1.45,"value":45422.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.43 to $1.45, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":62668,"source":{"system":"sec-edgar","filing":"0001641172-25-006115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000164117225006115/ownership.xml","form_type":"4"}},{"id":1276953,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80509,"kind":"person","name":"Becher Charles","position":1,"cik":"0001775310","reported_name":"Becher Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-11T02:30:14.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":70671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in two equal installments on the 90th and 180th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 23,323 shares of common stock and (ii) 70,671 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":93994,"source":{"system":"sec-edgar","filing":"0001493152-25-005764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225005764/ownership.xml","form_type":"4"}},{"id":1698893,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80509,"kind":"person","name":"Becher Charles","position":1,"cik":"0001775310","reported_name":"Becher Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-28T22:30:09.000Z","date":"2023-12-26","kind":"exercise","planned":false,"acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in eleven (11) equal quarterly installments from February 29, 2024 to August 29, 2026. The options become exercisable upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The options will vest in eleven (11) equal quarterly installments from February 29, 2024 to August 29, 2026. The options become exercisable upon vesting."}],"balance_after":275000,"derivative":{"exercise_price":0.419,"expiration_date":"2032-08-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-23-046419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223046419/ownership.xml","form_type":"4"}},{"id":1698892,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":80509,"kind":"person","name":"Becher Charles","position":1,"cik":"0001775310","reported_name":"Becher Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-28T22:30:09.000Z","date":"2023-12-26","kind":"exercise","planned":false,"acquired":true,"shares":125000,"price":0.419,"value":52375.0,"ownership":{"direct":true},"balance_after":233227,"source":{"system":"sec-edgar","filing":"0001493152-23-046419","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223046419/ownership.xml","form_type":"4"}}]}